I do both neoadjuvant and concurrent. The strategy used is typically dictated by patient schedule/convenience.While GETUG-AFU 16 used a concurrent approach, SPPORT utilized a 2-month neoadjuvant strategy for ADT.

I do concurrent. In GETUG-AFU 16, goserelin was administered on day 1 of radiotherapy and then 3 months later for a 6-month course. Unsure what the biologic rationale would be to start ADT prior to radiation in the post-prostatectomy setting.